1. Home
  2. CCO vs TYRA Comparison

CCO vs TYRA Comparison

Compare CCO & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.38

Market Cap

1.2B

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$37.64

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
TYRA
Founded
1995
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
CCO
TYRA
Price
$2.38
$37.64
Analyst Decision
Hold
Strong Buy
Analyst Count
6
10
Target Price
$2.12
$46.78
AVG Volume (30 Days)
9.1M
931.7K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
110.81
N/A
EPS
0.04
N/A
Revenue
$1,604,140,000.00
N/A
Revenue This Year
$5.29
N/A
Revenue Next Year
$4.09
N/A
P/E Ratio
$59.25
N/A
Revenue Growth
6.57
N/A
52 Week Low
$0.86
$6.42
52 Week High
$2.43
$40.65

Technical Indicators

Market Signals
Indicator
CCO
TYRA
Relative Strength Index (RSI) 52.67 55.40
Support Level $2.33 $34.01
Resistance Level $2.41 $39.15
Average True Range (ATR) 0.02 2.40
MACD -0.01 -0.06
Stochastic Oscillator 44.44 54.97

Price Performance

Historical Comparison
CCO
TYRA

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: